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), as sodium nitrite, or derived from dietary nitrate found in green leafy 
vegetables and beetroot, has potential as a tolerance-free therapy in Heart Failure with 
Preserved Ejection Fraction (HFpEF)(1) including pulmonary hypertension-associated 
HFpEF (PH-HFpEF) (2). Nitrite affects small and large arteries and veins.  Previous studies 
demonstrated hypoxia (versus normoxia) enhanced nitrite-induced dilatation by 30-50% in 
small resistance arterioles, but not veins (since venous blood is already desaturated) (3).  We 
recently demonstrated that nitrite selectively dilates peripheral conduit arteries in a normoxia-
dependent/hypoxia-inhibited manner, and selectively lowers aortic blood pressure 
(afterload)(4). We confirmed this latter effect with 6 months’ dietary nitrate (beetroot juice) 
in 126 patients(5). Nitrite has similar selectivity as nitroglycerin (GTN) for conduit, versus 
small resistance arterioles(4). We therefore investigated whether nitrite also selectively 
vasodilates epicardial coronary (conduit) arteries. 
 
Following institutional and ethical approvals and informed consent, we recruited patients 
undergoing diagnostic coronary angiography, including those with an angiographically-
normal coronary artery/without previous coronary intervention.  
 
A 0.014-inch coronary Doppler wire (Flow Wire, Phillips Volcano, USA) was positioned 
within the proximal artery and average peak velocity (APV) measured following five-minute 
infusions of 0.9% saline (baseline), low-dose sodium nitrite (2.6mol/min), high-dose 
sodium nitrite (26mol/min), and GTN (1g/min).  Angiographic images were obtained 
simultaneously.  Quantitative Coronary Analysis (QCA) was performed off-line with 
measurements of vessel diameter (d) in the 5mm segment distal to the tip of the Doppler 
wire.   Coronary blood flow (CBF, cm
3
/s) was calculated by:  CBF= (APV/2) x cross-
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sectional area. Coronary resistance (mmHg/cm
3
/s) was calculated as mean arterial pressure 
divided by coronary blood flow.   
 
Nine patients (mean age 56 years, 5 male, 78% hypertensive) received both doses of nitrite, 
and GTN, and had angiographic and Doppler flow traces of sufficient quality to be included 
in the analysis. The higher dose of nitrite (26mol/min) and GTN both significantly dilated 
the coronary artery compared to baseline: diameter-change (mean [95% CI]): +8.9% 
[+2.0,+15.8], p=0.01 and +10.8% [+1.0,+20.5] p=0.03, respectively (Figure 1A); with no 
significance difference between nitrite and GTN (p=0.45). Lower dose nitrite (2.6mol/min) 
had no significant effect (+3.9% [-2.8,+10.6], p=0.3). 
 
GTN increased coronary flow relative to baseline (median [interquartile range]): +23.9% 
[+6.3,+72.7], p=0.02.  Nitrite (2.6mol/min and 26mol/min) lacked significant effect on 
coronary flow: +12.0% [-10.2, +24.1] p>0.99 and +16.9% [+3.2, +64.4] p>0.99 respectively.  
This was despite relatively high estimated intracoronary nitrite concentrations 73.7 [57.8, 
154.9] microM(median [IQR]) for nitrite (2.6mol/min) and 705 [555, 1179]microM 
(median [IQR]) for nitrite (26mol/min).   
 
GTN also lowered coronary resistance relative to baseline (mean [95% CI]): -29.3% [-52.8,-
5.9] p=0.02, and versus nitrite (26mol/min): -10.4% [-18.3,-2.4] p=0.01. By contrast, nitrite 
(2.6mol/min and 26mol/min) had no significant effect on coronary resistance: -11.1% [-




There were no significant overall differences in central systolic, diastolic, or mean blood 
pressure with any of the interventions versus baseline. Heart rate changed -3.1 bpm [-0.2,-
6.1], p=0.02, with nitrite (2.6mol/min), but not with nitrite (26mol/min) or GTN. 
 
In summary, this is the first data to show that inorganic nitrite dilates epicardial coronary 
arteries; moreover, this was selective (and dose-dependent). Whilst the results should be 
interpreted with caution, given the small sample size, the indirect measures of coronary flow, 
and the trend towards a change in coronary flow/resistance, they support our findings in the 
peripheral circulation(4) of nitrite’s physiological action as a normoxia-dependent selective 
conduit artery dilator over  resistance arteries, even in the metabolically-active myocardium.  
These findings also have important implications for our understanding of the potential 
beneficial cardiovascular properties of nitrite derived from dietary nitrate sources such as 
beetroot and green leafy vegetables:  nitrite acts principally on large, rather than small vessels 




Figure 1. Percentage change in: A coronary artery diameter, and B coronary resistance. 
Nitrite (2.6) and Nitrite (26) denote nitrite (2.6 mol/min) and nitrite (26 mol/min), 
respectively. Data shown as Mean±SEM. Significance shown as *p<0.05 vs baseline, 
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